ACCESSIBILITY OF ORPHAN DRUGS IN FRANCE, UNITED KINGDOM AND GERMANY: DIFFERENT APPROACHES WITH REGARD TO HTA AND PRICES

被引：0
|
作者：
Grandfils, N. [1 ]
Hounkanlin, H. [1 ]
Troubat, A. [1 ]
机构：
[1] IMS Hlth, Paris, France
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.773
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A457 / A457
页数：1
相关论文
共 50 条
  • [1] HTA ASESSMENT COMPARISON OF ORPHAN DRUGS IN FRANCE AND GERMANY
    Remuzat, C.
    Mzoughi, O.
    Rodrigues, J.
    Korchagina, D.
    Toumi, M.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A236 - A237
  • [2] HTA OUTCOMES FOR ORPHAN DRUGS IN ONCOLOGY: COMPARISON OF FRANCE, GERMANY AND ENGLAND
    Jaroslawski, S.
    Toumi, M.
    Korchagina, D.
    Auquier, P.
    Dussart, C.
    [J]. VALUE IN HEALTH, 2018, 21 : S111 - S111
  • [3] ACCESS TO ORPHAN ONCOLOGY DRUGS IN FRANCE VERSUS THE UNITED KINGDOM
    Esmail, S.
    Grosvenor, A. S.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A18 - A18
  • [4] COMPARISON OF DRUG ASSESSMENTS IN FRANCE, GERMANY AND THE UNITED KINGDOM: IS EUROPEAN HTA A REALITY?
    Troubat, A.
    Perrin, L.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A482 - A482
  • [5] COMPARISON OF ADDITIONAL BENEFIT RATING AND DRUG PRICES FOR ORPHAN DRUGS IN FRANCE AND GERMANY
    Oku, Y.
    Fukushima, A.
    Dorey, J.
    Toumi, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S107 - S107
  • [6] PHARMACOECONOMIC EVALUATION OF ORPHAN DRUGS IN THE UNITED KINGDOM, FRANCE, ITALY, TURKEY AND EXPLORATION OF THE EVALUATION PROCESS OF ORPHAN DRUGS IN ALGERIA
    Kebaili, H.
    Djahdou, Z.
    Amrani, I
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S235 - S235
  • [7] IMPACT OF MULTI-DRUG RESISTANCE ON HTA ASSESSMENT OF ANTIBIOTICS IN FRANCE, GERMANY, UNITED KINGDOM
    Charafi, N.
    Chen, X.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A677 - A677
  • [8] Access to innovative cancer drugs: Divergent outcomes of HTA bodies' appraisals in France, Germany and the United Kingdom impact on the availability of new medicines
    Hartmann, M.
    Droeschel, D.
    Vollmer, L.
    De Paz, B.
    Walzer, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 72 : S115 - S115
  • [9] Determinants of orphan drugs prices in France: a regression analysis
    Daria Korchagina
    Aurelie Millier
    Anne-Lise Vataire
    Samuel Aballea
    Bruno Falissard
    Mondher Toumi
    [J]. Orphanet Journal of Rare Diseases, 12
  • [10] Determinants of orphan drugs prices in France: a regression analysis
    Korchagina, Daria
    Millier, Aurelie
    Vataire, Anne-Lise
    Aballea, Samuel
    Falissard, Bruno
    Toumi, Mondher
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
12345